A novel palladium-mediated coupling approach to 2,3-disubstituted benzo[b]thiophenes and its application to the synthesis of tubulin binding agents

Organic Letters

Volumn 3, Issue 5, 2001, Pages 651-653

  Flynn, Bernard L ^a   Verdier Pinard, Pascal ^b   Hamel, Ernest ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOTHIOPHENE; COLCHICINE; PALLADIUM; THIOPHENE DERIVATIVE; TUBULIN;

ARTICLE; CATALYSIS; CELL CULTURE; CHEMISTRY; HUMAN; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CATALYSIS; COLCHICINE; HUMANS; PALLADIUM; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0035826341     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0067179     Document Type: Article

References (42)

1. For reviews on the synthesis and application of benzo[b]thiophenes, see: (a) Zhang, T. Y.; O'Toole, J.; Proctor, C. S. Sulfur Kep. 1999, 22, 1.
2. (b) Pelkey, E. T. Prog. Heterocycl. Chem. 1999, 11, 102.
3. (c) Bianchini, C.; Meli, A. Synlett 1997, 643.
4. (d) Russell, R. K.; Press, J. B. Compr. Heterocycl. Chem. II 1996, 2, 679.
5. (e) Irie, M.; Uchida, K. Bull. Chem. Soc. Jpn. 1998, 71, 985.
6. (a) Magarian, R. A.; Overacre, L. B.; Singh, S.; Meyer, K. L. Curr. Med. Chem. 1994, 1, 61.
7. (b) Jones, C. D.; Jevnikar, M. G.; Pike, A. J.; Peters, M. K.; Black, L. J.; Thompson, A. R.; Falcone, J. F.; Clemens, J. A. J. Med. Chem. 1984, 27, 1057.
8. (c) Bryant, H. U.; Dere, W. H. Proc. Soc. Exp. Biol. Med. 1998, 217, 45.
9. (a) Pinney, K. G.; Bounds, A. D.; Dingeman, K. M.; Mocharla, V. P.; Pettit, G. R.; Bai, R.; Hamel, E. Bioorg. Med. Chem. Lett. 1999, 9, 1081.
10. (b) Pinney, K. G.; Pettit, G. R.; Mocharla, V. P.; Del, P. M. M.; Shirali, A. PCT Int. Appl. WO 98 39 323 (Chem. Abstr. 1998, 129, 245037c).
11. (c) Zhang, S.-X.; Bastow, K. F.; Tachibana, Y.; Kuo, S.-C.; Hamel, E.; Mauger, A.; Narayanan, V. L.; Lee, K.-H. J. Med. Chem. 1999, 42, 4081.
12. Norman, B. H.; Dantzig, A. H.; Kroin, J. S.; Law, K. L.; Tabas, L. B.; Shepard, R. L.; Palkowitz, A. D.; Hauser, K. L.; Winter, M. A.; Sluka, J. P.; Starling, J. J. Bioorg. Med. Chem. Lett. 1999, 9, 3381.
13. (a) Boschelli, D. H.; Kramer, J. B.; Connor, D. T.; Lesch, M. E.; Schrier, D. J.; Ferin, M. A.; Wright, C. D. J. Med. Chem. 1994, 17, 717.
14. (b) Cobb, R. R.; Felts, K. A.; McKenzie, T. C.; Parry, G. C. N.; Mackman, N. FEBS Lett. 1996, 382, 323.
15. (c) Gualberto, A.; Marquez, G.; Garballo, M.; Youngblood, G. L.; Hunt, S. W., III; Baldwin, A. S.; Sobrino, F. J. Biol. Chem. 1998, 273, 7088.
16. (a) Martel, A. M.; Prous, J.; Castaner-Prous, J. Drugs Future 1997, 22, 386.
17. (b) Miyazaki, H.; Murayama, T.; Ono, S.; Narita, H.; Nomura, Y. Biochem. Pharmacol. 1997, 53, 1263.
18. (a) Thesen, R. Pharm. Ztg. 1995, 140, 44.
19. (b) Raga, M.; Palacin, C.; Castello, J. M.; Ortiz, J. A.; Cuberes, M. R.; Moreno-Manas, M. Eur. J. Med. Chem.-Chim. Ther. 1986, 21, 329.
20. (a) Bleavins, M. R.; de la Igelsia, F. A.; McCay, J. A.; White, L.; Kimber, L., Jr.; Munson, A. E. Toxicology 1995, 98, 111.
21. (b) Wright, C. D.; Stewart, S. F.; Kuipers, P. J.; Hoffman, M. D.; Devall, L. J.; Kennedy, J. A.; Ferin, M. A.; Theuson, D. O.; Conroy, M. C. J. Leukocyte Biol. 1994, 55, 443.
22. (a) Bradley, D. A.; Godfrey, A. G.; Schmid, C. R. Tetrahedron Lett. 1999, 40, 5155.
23. (b) Gallagher, T.; Pardoe, D. A.; Porter, R. A. Tetrahedron Lett. 2000, 41, 5415.
24. (c) Arnau, N.; Moreno-Manas, M.; Pleixats, R. Tetrahedron 1993, 49, 11019.
25. (d) McDonald, F. E.; Burova, S. A.; Huffman, L. G., Jr. Synthesis 2000, 970.
26. Sakamoto, T.; Kondo, Y.; Uchiyama, M.; Yamanaka, H. J. Chem. Soc., Perkin Trans. 1 1993, 1941.
27. Xiao, W.-J.; Alper, H. J. Org. Chem. 1999, 64, 9646.
28. See also Supporting Information.
29. (a) Banwell, M. G.; Flynn, B. L.; Willis, A. C.; Hamel, E. Aust. J. Chem. 1999, 52, 767.
30. (b) Banwell, M. G.; Flynn, B. L.; Hockless D. C. R. Chem. Commun. 1997, 2259.
31. Salaun, J. J. Org. Chem. 1977, 42, 28.
32. For some other examples of iodocyclization involving alkynyl benzyl sulfides, see: (a) Ren, X.-F.; Turos, E. Tetrahedron Lett. 1993, 34, 1575.
33. (b) Ren, X.-F.; Turos, E.; Lake, C. H.; Churchill, M. R. J. Org. Chem. 1995, 60, 6468.
34. For related iodocyclizations of o-ethynylphenols to give 3-iodobenzo[b]furans, see ref 13a and the following: Arcadi, A.; Cacchi, S.; Giancarlo, F.; Marinelli, F.; Moro, L. Synlett 1999, 1432.
35. Banwell, M. G.; Flynn, B. L.; Stewart, S. G. J. Org. Chem. 1998, 63, 9139.
36. Carreno, M. C.; Garcia Ruano, J. L.; Sanz, G.; Toledo, M. A.; Urbano, A. J. Org. Chem. 1995, 60, 5328.
37. Ciattini, P. G.; Morera, E.; Ortar, G. Tetrahedron Lett. 1995, 36, 4133.
38. Attempts to introduce the benzylthiol by palladium-mediated substitution of the aryl bromide in 30 with benzyl mercaptan have so far failed.
39. For a review, see: Sackett, D. L. Pharmacol. Ther. 1993, 59, 163.
40. Dark, G. G.; Hill, S. A.; Prise, V. E.; Tozer, G. M.; Pettit, G. R.; Chaplin, D. J. Cancer Res. 1997, 57, 1829.
41. See ref 13a and references cited therein.
42. During the course of these studies, Pinney and co-workers also prepared compound 14: Pinney, K. G.; Chen, Z.; Mocharla, V. P.; Choony, N.; Strong, T. Synthesis of a Benzo[b]thiophene-Based Vascular Targeting Prodrug and Related Anti-Tubulin Ligands. Abstracts of Papers, 220th National Meeting of the American Chemical Society, Division of Organic Chemistry; Washington, D.C., August 20-24, 2000; American Chemical Society: Washington, D.C., Abstract No. 196.